Labroots

The Role of Interferon Gamma Release Assay (IGRA) Testing in the TB Testing Program

The goal of TB elimination, less than 1 case per million people per year, can only be achieved through a concerted effort to detect and treat persons infected with TB, which includes those persons ...
Labroots

The Role of Interferon Gamma Release Assay (IGRA) Testing in the era of COVID-19

This is the second World TB Day and the end of the first full year since the world encountered COVID-19. We have all worked feverishly to manage this pandemic and its consequences. What impact has ...
News Medical

New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis

In a recent study published in JAMA Network Open, researchers compared the performance of tuberculin skin test (TST) and interferon-γ release assays (IGRAs) in predicting tuberculosis (TB). Study: ...
Business Wire

QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON ®-TB Gold Plus assay on LIAISON ® XS

HILDEN, Germany & SALUGGIA, Italy--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) and DiaSorin (FTSE MIB: DIA) today announced that the U.S. Food and Drug Administration (FDA) has ...

QIAGEN Plans to Launch New Fully Automated Sample to Insight Workflow and an AI-Enabled Risk Stratification Tool to Advance QuantiFERON Latent TB Testing

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced plans to advance its QuantiFERON latent tuberculosis ...